Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Net Margin (2016 - 2025)

Firefly Neuroscience has reported Net Margin over the past 15 years, most recently at 659.95% for Q4 2025.

  • Quarterly results put Net Margin at 659.95% for Q4 2025, up 648156.0% from a year ago — trailing twelve months through Dec 2025 was 2148.07% (up 753711.0% YoY), and the annual figure for FY2025 was 2148.07%, up 753711.0%.
  • Net Margin for Q4 2025 was 659.95% at Firefly Neuroscience, up from 680.15% in the prior quarter.
  • Over the last five years, Net Margin for AIFF hit a ceiling of 7.92% in Q1 2021 and a floor of 40325.58% in Q1 2025.
  • Median Net Margin over the past 5 years was 519.54% (2025), compared with a mean of 5320.99%.
  • Peak annual rise in Net Margin hit 1231682bps in 2025, while the deepest fall reached -3097558bps in 2025.
  • Firefly Neuroscience's Net Margin stood at 2.22% in 2021, then tumbled by -19077bps to 426.03% in 2022, then skyrocketed by 101bps to 4.66% in 2023, then crashed by -153422bps to 7141.51% in 2024, then surged by 91bps to 659.95% in 2025.
  • The last three reported values for Net Margin were 659.95% (Q4 2025), 680.15% (Q3 2025), and 613.04% (Q2 2025) per Business Quant data.